Symposium 2013 Video

Symposium Welcome and Introduction,
Molecular Profiling in Cancer: Research or Practice?
Molecular Profiling 101



Welcome and Introduction
John Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center


Molecular Profiling 101
Michael A. Pacanowski, Pharm.D., M.P.H.
Associate Director, Genomics and Targeted Therapy, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, FDA

Chip Petricoin, PhD
Co-Director, Center for Applied Proteomics & Molecular Medicine, Professor of Life Sciences, George Mason University

Gary Palmer, MD, JD, MBA, MPH
Senior Vice President of Foundation Medicine, Medical Affairs and Commercial Development

Jeffrey Roche, MD, MPH
Lead Medical Officer, Centers for Medicare and Medicaid Services, Coverage Analysis Group


Schafer Lecture



Manuel Hidalgo, MD, PhD
Associate Professor of Oncology, Johns Hopkins University School of Medicine; Director, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain

The Thomas R. Schafer Memorial Lecture Fund for Research and Education in Pancreatic and Gastrointestinal Cancer was established in 1999 as a tribute by the late Thomas Schafer's family and friends. They felt strongly that his spirit should live on through this fund for an annual lectureship, designed to discuss the latest concepts and innovations in cancer therapy.


Profiling in Practice - Case Study Presentations



Moderator – TBA

Hartmut Juhl. MD
Associate Professor for Oncology and Surgery at Georgetown University; Founder and Chief Executive Officer, Indivumed

Ira Klein, MD, MBA
Senior Medical Director, National Accounts Clinical Sales and Strategy, Aetna

Joe V. Selby, MD, MPH
Executive Director of Patient-Centered Outcomes Research Institute

Gilad Gordon, MD, MBA
President, Orra Group, LLC; Clinical Associate Professor, University of Colorado Denver

Mace Rothenberg, MD
Senior VP, Clinical Development and Medical Affairs, Oncology Business Unit, Pfizer, Inc.